查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049621

數位療法市場報告：按應用、最終用途和地區分類（2026-2034 年）

Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球數位療法市場規模達83億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以15.45%的複合年成長率成長，到2034年達到314億美元。北美憑藉其完善的醫療基礎設施、顯著的技術進步以及對數位醫療的大量投資，成為該市場的主導地區。此外，醫療成本的上升、慢性病盛行率的增加、老年人口的成長以及技術進步帶來的便利、經濟高效且個人化的醫療服務，也推動了該市場的擴張。

市場規模及預測：

  • 到2025年，數位療法市場價值將達到83億美元。
  • 預計從 2026 年到 2034 年，該產業將以 15.45% 的複合年成長率成長，到 2034 年達到 314 億美元。

主要部分：

  • 應用領域：由於糖尿病在世界各地的盛行率不斷上升，糖尿病佔據了最大的市場佔有率。
  • 最終用戶：由於以患者為中心的醫療保健模式的擴展以及智慧型手機和網際網路服務的廣泛使用，使得患者可以輕鬆訪問治療應用程式，因此患者現在佔據了最大的市場佔有率。
  • 地區：北美是關鍵地區，因為其擁有完善的醫療保健基礎設施，並在數位健康技術領域進行了大量投資。

主要公司：

  • 市場上的主要參與者包括 2Morrow Inc.、Canary Health Inc.、Click Therapeutics Inc.、Mango Health Inc.（TrialCard Incorporated）、Noom Health Inc.、Omada Health Inc.、Pear Therapeutics, Inc.、Propeller Health（ResMed）、Teladoc Health Inc.、Volocis Inc. 和 WellD. Inc. 和 Welladoc Health Inc.、Volocis Inc.。

市場成長的主要促進因素：

  • 健康意識的提高：人們對慢性病和心理健康的認知不斷提高，推動了提供經濟高效且個人化護理的數位療法市場的發展。
  • 科技創新：行動醫療應用、穿戴式裝置和數據分析領域的持續創新，使數位治療方案更加有效和普及。
  • 監管支持：各國政府和監管機構正透過新的法規和報銷模式，積極推動在醫療保健系統中引入和使用數位療法。
  • 醫療保健系統的負擔：隨著醫療保健系統面臨越來越大的壓力，需要降低成本並改善患者療效，醫療保健提供者擴大採用數位療法作為傳統治療方法的低成本替代方案。
  • 個人對便利性的需求：對遠距照護和健康狀況自我管理的需求不斷成長，推動了兼具便利性和柔軟性的數位醫療解決方案的普及。

未來展望：

  • 強勁的成長前景：在技術進步、監管核准加速以及對個人化醫療保健解決方案的需求不斷成長的推動下，數位療法市場正在快速成長。
  • 市場演變：市場正從最初的引進階段轉向更廣泛的應用，涵蓋多個治療領域，包括慢性病管理、心理健康和預防。

數位療法市場的發展趨勢：

醫療領域的技術發展

在持續的技術進步推動下，數位療法市場正以驚人的速度成長，尤其是在行動應用、人工智慧 (AI) 和機器學習 (ML) 領域。這些進步促進了複雜數位平台的構建，從而能夠提供個人化的治療方案、處理大量的健康數據並即時追蹤患者的活動。基於人工智慧的演算法正在提升診斷能力，實現疾病的早期診斷和更精準的干涉。此外，穿戴式技術的開發，能夠補充血壓、心率和血糖值等各種生理指標，使患者和醫療專業人員能夠在疾病管理中發揮更積極的作用。將這些技術整合到醫療保健系統中，將透過消除面對諮詢的需求，改善患者的治療效果，並使治療更加便利有效。根據 IMARC 集團預測，到 2033 年，全球醫療保健領域的人工智慧市場規模預計將達到 687 億美元。

慢性病發生率增加

慢性病發生率的上升是推動市場發展的關鍵因素之一。糖尿病、肥胖症、心血管疾病和呼吸系統疾病等慢性病在全球日益普遍，這主要是由於人口老化、缺乏運動和不健康飲食等因素造成的。數位療法透過提供即時監測和個人化干預，為疾病的長期管理提供了解決方案。例如，糖尿病患者可以使用數位平台監測血糖值、調整胰島素劑量，並根據即時回饋獲得飲食建議。同樣，心臟病患者可以利用數位療法追蹤生命徵象、接收基準值結果通知，並遵循處方治療方案。這些技術使患者能夠更好地管理自身健康狀況，減少就醫次數，並提高整體生活品質。 2024 年，數位療法™作為處方藥解決方案的先驅 Click Therapeutics, Inc. 宣布，計劃透過收購 Better Therapeutics, Inc. 的資產來加速肥胖症和心血管代謝疾病領域的發展。收購的資產包括 AspyreRx (BT-001)，這是第一個核准FDA處方箋醫療器材認定，用於治療代謝紊亂相關脂肪性肝炎 (MASH)。

對個人化醫療保健的需求日益成長

根據《數位療法市場報告》，個人化醫療正成為醫學的核心關注點。患者越來越期望獲得量身定做的治療方法，這些方案需考慮遺傳因素、生活方式和特定健康狀況等因素。數位療法能夠利用即時資訊客製化治療方案，使臨床醫生提供更個人化的照護。這些平台可以利用穿戴式裝置的數據、健康史和自我報告的資訊來制定高度個人化的治療方案。例如，心理健康應用程式可以利用患者的情緒、睡眠和行為訊息來客製化認知行為療法 (CBT) 等治療方法。同樣，針對慢性疾病的數位療法可以追蹤疾病進展，並根據這些資訊調整治療方案。個人化醫療正在革新醫學，透過賦予患者積極管理自身健康的能力，提高治療效果和患者參與度。隨著對個人化治療需求的成長，數位療法正成為個人化治療的重要組成部分。 2024 年，Merz Therapeutics 推出了 iFlexo，這是一款旨在改善中風後痙攣患者復原的個人化數位解決方案。這體現了該公司對中風倖存者的持續支持。該應用程式由 Merz Therapeutics 與 S3 Connected Health 合作開發，提供針對輕度至中度痙攣患者的特定運動和復健計劃，旨在提高他們的活動能力。 iFlexo 透過一套系統化的運動方案，旨在幫助中風倖存者重拾獨立生活能力，並提升他們的整體生活品質。 Merz Therapeutics 是唯一一家專注於神經毒素並同時提供自我康復支持平台的製藥公司。

數位療法市場成長要素：

監管支援和醫療費用報銷

數位療法產業的關鍵驅動力之一是監管機構對這些平台的支持力度不斷增加以及報銷機制的建立。美國食品藥物管理局（FDA）等監管機構正積極致力於檢驗數位療法作為適當醫療干預措施的有效性。 FDA制定了新的軟體治療方法核准指南，簡化了數位療法公司將其產品推向市場的流程。這種監管核準確保了數位療法的安全性和有效性，從而提高了醫療專業人員和患者的接受度。此外，保險公司也認知到這些解決方案在改善患者療效和降低醫療成本方面的價值，並正在調整其報銷政策以涵蓋數位療法。隨著數位治療方法的保險覆蓋範圍擴大，這些解決方案的經濟可及性也在提高，使更多患者受益。這些監管和保險覆蓋方面的進展正在為數位治療方法在主流醫療機構中的更廣泛應用鋪平道路。

人們越來越關注心理健康

人們對心理健康障礙的日益關注正在推動市場成長。焦慮症、憂鬱症和創傷後壓力症候群（PTSD）等心理健康障礙的發生率不斷上升，使得人們對有效且價格合理的治療方法的需求日益成長。數位療法透過提供擴充性且易於實施的居家解決方案，為治療心理健康障礙開闢了新的可能性。行動應用程式、線上治療網站和電腦化認知行為療法（CBT）程式正變得越來越受歡迎，因為它們為患者提供了傳統面對面治療之外的另一種選擇。這些選擇對於居住在農村或發展中地區、難以獲得心理健康專業人員的人尤其有用。此外，線上心理健康網站提供一定程度的匿名性，可以減少尋求協助所帶來的恥辱感。

消費者對便利性和遠端醫療的偏好

人們對便利的遠端醫療產品和服務的偏好日益成長，推動了市場成長。現今的患者越來越傾向於選擇能夠融入其積極生活方式的醫療保健解決方案，而無需反覆前往診所和醫院。數位療法透過提供隨時隨地可用的工具來滿足這一需求，使患者能夠按照自己的步調管理健康。例如，慢性病患者可以使用行動應用程式和穿戴式技術來監測症狀和生命徵象，並獲得治療建議。此外，數位平台還支援與醫療專業人員進行遠距諮詢，從而減少了住院次數，並有助於降低醫療保健成本。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球數位療法市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依應用領域分類

  • 糖尿病
  • 肥胖
  • CVD
  • 中樞神經系統疾病
  • 呼吸系統疾病
  • 禁止抽煙
  • 其他

第7章 市場區隔：依最終用途分類

  • 病人
  • 提供者
  • 付款人
  • 雇主
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • 2Morrow Inc.
    • Canary Health Inc.
    • Click Therapeutics Inc.
    • Mango Health Inc.（TrialCard Incorporated）
    • Noom Health Inc.
    • Omada Health Inc.
    • Pear Therapeutics, Inc.
    • Propeller Health（ResMed）
    • Teladoc Health Inc.
    • Voluntis Inc.
    • WellDoc Inc.
Product Code: SR112026A3889

The global digital therapeutics market size reached USD 8.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 31.4 Billion by 2034, exhibiting a growth rate (CAGR) of 15.45% during 2026-2034. North America is the dominant region in the market because it has an established healthcare infrastructure, strong technology advancements, and high investment in digital health in the region. Moreover, the market is expanding due to rising healthcare expenditure, increasing prevalence of chronic diseases, the growing geriatric population, and technological advancements offering easily accessible, cost-effective, personalized medical treatments.

MARKET SIZE & FORECASTS:

  • Digital therapeutics market was valued at USD 8.3 Billion in 2025.
  • The market is projected to reach USD 31.4 Billion by 2034, at a CAGR of 15.45% from 2026-2034.

DOMINANT SEGMENTS:

  • Application : Diabetes holds the largest market share owing to the rising occurrence of diabetes among the masses globally.
  • End Use: Patients hold the biggest market share due to the growing patient-focused healthcare model and the extensive use of smartphones and internet services, which enable straightforward access to therapeutic apps.
  • Region: North America represents the leading region because of the presence of a well-established healthcare infrastructure, along with the significant investments in digital health technologies in the region.

KEY PLAYERS:

  • The leading companies in the market include 2Morrow Inc., Canary Health Inc., Click Therapeutics Inc., Mango Health Inc. (TrialCard Incorporated), Noom Health Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health Inc., Voluntis Inc., WellDoc Inc., etc.

KEY DRIVERS OF MARKET GROWTH:

  • Emerging Health Consciousness: Growing consciousness about chronic illnesses and mental health conditions is propelling the market for digital therapeutics, providing cost-effective and personalized care.
  • Technological Innovation: Continuing innovations in mobile health apps, wearables, and data analytics are making digital therapeutic solutions more effective and accessible.
  • Regulatory Backing: Governments and regulators are actively promoting the adoption of digital therapeutics in healthcare systems through novel regulation and reimbursement models, driving their usage.
  • Burden to Healthcare Systems: Increasing stress on healthcare systems to decrease costs and enhance patient outcomes is encouraging providers to embrace digital therapeutics as a less expensive alternative to conventional treatments.
  • Convenience Demand from Individuals: Growing demand for remote care and health condition self-management is driving the use of digital therapeutic solutions that are convenient and flexible.

FUTURE OUTLOOK:

  • Strong Growth Outlook : The market for digital therapeutics is growing rapidly, with improving technology, accelerating regulatory approval, and growing demand for customized healthcare solutions.
  • Market Evolution : The market is transforming from nascent adoption to more universal application in multiple therapeutic areas, such as chronic disease management, mental health, and prevention.

DIGITAL THERAPEUTICS MARKET TRENDS :

Technological Developments in Healthcare

The market for digital therapeutics is growing at a rapid pace because of the relentless progress in technology, especially in mobile applications, artificial intelligence (AI), and machine learning (ML). These advancements are facilitating the creation of advanced digital platforms that are capable of providing customized treatment plans, processing large volumes of health data, and tracking patient activity in real-time. Algorithms based on AI are enhancing diagnostic capabilities, enabling early diagnosis of disease and more targeted interventions. Additionally, the development of wearable technology, which complements different physiological measures, such as blood pressure, heart rate, and blood glucose levels, is facilitating patients and healthcare workers to be proactive in disease management. The integration of these technologies into healthcare systems is enhancing patient outcomes and eliminating the necessity for in-person consultations, making treatment more convenient and effective. IMARC Group predicts that the global artificial intelligence in healthcare market is projected to reach USD 68.7 Billion by 2033.

Rising Incidence of Chronic Diseases

The rising occurrence of chronic diseases is one of the primary drivers of market. Chronic diseases like diabetes, obesity, cardiovascular diseases, and respiratory ailments are becoming prevalent globally, largely because of reasons such as aging populations, a lack of physical activity, and unhealthy diets. Digital therapeutics provide a solution for long-term condition management by offering real-time monitoring and tailored interventions. For instance, diabetic patients can use digital platforms to monitor their blood glucose levels, modify their insulin dosage, and get diet suggestions based on real-time feedback. Likewise, heart disease patients can utilize digital therapeutics to track vital signs, get notifications for out-of-range results, and follow prescribed treatment protocols. These technologies allow for patients to better control their conditions, minimizing the need for repeated trips to the hospital and enhancing their overall quality of life. In 2024, Click Therapeutics, Inc., a frontrunner in Digital Therapeutics(TM) as prescription medical solutions, revealed intentions to expedite its development efforts in obesity and cardiometabolic conditions through purchasing the assets of Better Therapeutics, Inc. The acquired assets comprise AspyreRx (BT-001), the inaugural FDA-authorized prescription digital intervention for type 2 diabetes, and BT-004, which recently received FDA Breakthrough Device Designation for addressing metabolic dysfunction-associated steatohepatitis (MASH).

Increased Demand for Personalized Healthcare

As per digital therapeutics market report, personalized healthcare is emerging as the central focus in medicine. Increasingly, patients expect therapies that are customized to their own requirements, including considerations such as genetics, lifestyle, and particular health status. Digital therapeutics allow clinicians to provide more personalized therapies by employing real-time information to customize treatment plans. The platforms can draw on data from wearable devices, health histories, and self-reported information to generate extremely personalized treatment plans. For instance, psychological apps utilize information regarding a patient's mood, sleep, and behavior to modify therapeutic treatments such as cognitive behavioral therapy (CBT). Likewise, chronic condition digital therapeutics are capable of tracking disease advancement and modifying treatments based on the information. Personalized healthcare is revolutionizing healthcare by enabling patients to actively manage their condition, enhancing both treatment efficacy and participation. With the need for personalized therapies increasing, digital therapeutics are becoming integral parts of personalized treatments. In 2024, Merz Therapeutics introduces iFlexo, a tailored digital solution designed to improve rehabilitation for individuals experiencing post-stroke spasticity, reflecting its continuous dedication to assisting stroke survivors. The application, created in partnership with S3 Connected Health, offers specific exercises and rehabilitation plans designed to enhance mobility for individuals experiencing mild to moderate spasticity. Through providing structured exercises, iFlexo seeks to assist stroke survivors in reclaiming their independence and enhancing their overall life quality. Merz Therapeutics is the sole pharmaceutical company specializing in neurotoxins that provides a platform for self-rehabilitation support.

DIGITAL THERAPEUTICS MARKET GROWTH DRIVERS:

Regulatory Support and Healthcare Reimbursement

One of the key drivers behind the digital therapeutics industry is the growing regulatory support and creation of reimbursement mechanisms for these platforms. Regulators such as the U.S. Food and Drug Administration (FDA) are actively engaging in the verification of digital therapeutics as proper medical interventions. The FDA has established new guidelines for the approval of software-based treatments, which is streamlining the process for digital therapeutics companies to take their products to market. This regulatory approval ensures that digital therapeutics are safe and effective, thus gaining more acceptance from healthcare providers and patients. Moreover, reimbursement policies are evolving to accommodate digital therapeutics, with more insurance companies recognizing the value of these solutions in improving patient outcomes and reducing healthcare costs. As reimbursement for digital therapies becomes more widespread, the financial accessibility of these solutions is improving, allowing more patients to benefit from them. This regulatory and reimbursement progress is paving the way for the broader adoption of digital therapeutics in mainstream healthcare.

Greater Emphasis on Mental Health

The increasing recognition of mental health disorders is supporting the market growth. Mental health disorders like anxiety, depression, and post-traumatic stress disorder (PTSD) are rising in frequency, and there is a growing need for effective, affordable treatments. Digital therapeutics are opening up new possibilities for treating mental health disorders by presenting scalable, easy-to-deliver solutions that can be delivered from home. Mobile apps, online therapy websites, and computerized cognitive behavioral therapy (CBT) programs are becoming increasingly popular as they provide patients with an option to standard in-office therapy. These options are especially useful for those who live in rural or underdeveloped areas, where access to mental health professionals is limited. In addition, online mental health websites offer a level of anonymity that can decrease the stigma of seeking help.

Consumer Preference for Convenience and Remote Healthcare

The preferences for convenient, remote healthcare products and services is bolstering the market growth. Today's patients increasingly want healthcare solutions that are integrated into their active lifestyle, so they can take care of themselves without having to pay repeated visits to clinics or hospitals. Digital therapeutics are addressing this need by offering tools that are available whenever and wherever needed, helping patients to control their health at their own pace. For instance, individuals suffering from chronic diseases can monitor their symptoms, monitor their vital signs, and receive treatment advice using mobile applications and wearable technology. Furthermore, digital platforms also facilitate remote consultations with medical professionals, curbing the necessity of travel and lowering healthcare expenses.

DIGITAL THERAPEUTICS MARKET SEGMENTATION:

Breakup by Application:

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Diabetes accounts for the majority of the market share

Diabetes holds the largest market share as it is a condition that affects millions globally. Additionally, digital therapeutics in this area leverage cutting-edge technology to monitor blood sugar levels, administer insulin doses, and provide personalized dietary and exercise recommendations. These tools aim to stabilize patient conditions and enhance the quality of life by making disease management more accessible and efficient. Hence, leading market players are introducing advanced product variants to meet these needs. For instance, on 16 October 2023, Better Therapeutics, Inc., a prominent leader in prescription digital therapeutics (PDTs) for cardiometabolic conditions, announced the commercial release of AspyreRx. This is the first cognitive behavioral therapy (CBT) app to gain U.S. Food and Drug Administration (FDA) approval as a Class II device for managing type 2 diabetes (T2D) in adults. It allows healthcare providers to prescribe AspyreRx, which is accessible for download from the Apple App Store and Google Play Store.

Breakup by End Use:

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Patients holds the largest share of the industry

According to the digital therapeutics industry overview, patients represent the largest segment due to the increasing patient-centric healthcare approach and the widespread adoption of smartphones and internet services, which facilitate easy access to therapeutic applications. These digital solutions offer patients tailored treatments for a range of conditions, including chronic diseases such as diabetes and hypertension, as well as mental health disorders. Additionally, the convenience and efficacy of these applications in managing health conditions through personalized care plans and real-time health tracking significantly contribute to their adoption among patients. This trend is further supported by growing healthcare digitization and a shift toward preventive healthcare measures, reinforcing the dominant position of patients in the digital therapeutics market. Therefore, major players are collaborating and launching sophisticated product variations. For instance, on 5 July 2023, ResMed announced the acquisition of Somnoware, a leading provider of digital diagnostics software for sleep and respiratory care. This acquisition expanded ResMed's sleep management software capabilities, facilitating more efficient patient diagnosis and long-term treatment through enhanced sleep labs and physician tools. The Somnoware platform will complement ResMed's existing post-testing solutions, AirView and Brightree, and will continue to operate as an open platform. This openness allows sleep labs, pulmonary function testing facilities, and physicians to access results from various testing solutions, accelerating the process of getting diagnosed patients the treatment they need.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest digital therapeutics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for digital therapeutics.

North America represents the leading region in the market. The digital therapeutics market growth factors for the region include the well-established healthcare infrastructure, robust technological advancements, and significant investment in digital health across the region. Moreover, the United States is primarily driven by the widespread adoption rate of digital health technologies among healthcare providers and patients alike. Besides, the presence of major digital therapeutics companies in North America, coupled with favorable government policies and a growing awareness about the benefits of digital therapeutics, further propel the market growth. For instance, on 7 November 2023, Vida Health, a leader in virtual cardiometabolic care, partnered with Withings Health Solutions, a key player in advanced everyday wearables, to provide top-tier digital monitoring devices to Vida members. This partnership offered eligible Vida members access to a Withings Body Pro cellular scale, a BPM Connect Pro cellular blood pressure monitor, or both. Vida's care teams gained reliable and consistent patient-generated health data, which enhanced their personalized care strategies and improved health outcomes by using these devices.

COMPETITIVE LANDSCAPE:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the digital therapeutics industry include 2Morrow Inc., Canary Health Inc., Click Therapeutics Inc., Mango Health Inc. (TrialCard Incorporated), Noom Health Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health Inc., Voluntis Inc., and WellDoc Inc.
  • At present, companies are strategically enhancing their offerings and expanding their reach to bolster growth in the digital therapeutics market. Additionally, central to their efforts is forging partnerships with established healthcare entities and insurers, which helps integrate digital therapeutics into mainstream medical practice and increases patient accessibility. Moreover, various innovations by firms are advancing their technologies to improve patient engagement and outcomes through more personalized and effective treatments. Along with this, regulatory approvals are aggressively pursued to ensure compliance and enhance market credibility, crucial for broader adoption. Besides, companies invest in educational campaigns to raise awareness among healthcare professionals and patients about the benefits of digital therapeutics, aiming to shift perceptions and foster trust. These combined efforts are essential for driving the adoption and long-term viability of digital therapeutics in the healthcare landscape.

Key Questions Answered in This Report

  • 1.What was the size of the global digital therapeutics market in 2025?
  • 2.What is the expected growth rate of the global digital therapeutics market during 2026-2034?
  • 3.What are the key factors driving the global digital therapeutics market?
  • 4.What has been the impact of COVID-19 on the global digital therapeutics market?
  • 5.What is the breakup of the global digital therapeutics market based on the application?
  • 6.What is the breakup of the global digital therapeutics market based on the end use?
  • 7.What are the key regions in the global digital therapeutics market?
  • 8.Who are the key players/companies in the global digital therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Diabetes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Obesity
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 CVD
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 CNS Disease
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Respiratory Diseases
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Smoking Cessation
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by End Use

  • 7.1 Patients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Providers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Payers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Employers
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 2Morrow Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Canary Health Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Click Therapeutics Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Mango Health Inc. (TrialCard Incorporated)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Noom Health Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Omada Health Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Pear Therapeutics, Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Propeller Health (ResMed)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Teladoc Health Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Voluntis Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 WellDoc Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Digital Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Therapeutics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Digital Therapeutics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Digital Therapeutics Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Digital Therapeutics Market: Breakup by End Use (in %), 2025
  • Figure 6: Global: Digital Therapeutics Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Digital Therapeutics (Diabetes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Digital Therapeutics (Diabetes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Digital Therapeutics (Obesity) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Digital Therapeutics (Obesity) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Digital Therapeutics (CVD) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Digital Therapeutics (CVD) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Digital Therapeutics (CNS Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Digital Therapeutics (CNS Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Digital Therapeutics (Respiratory Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Digital Therapeutics (Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Digital Therapeutics (Smoking Cessation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Digital Therapeutics (Smoking Cessation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Digital Therapeutics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Digital Therapeutics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Digital Therapeutics (Patients) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Digital Therapeutics (Patients) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Digital Therapeutics (Providers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Digital Therapeutics (Providers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Digital Therapeutics (Payers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Digital Therapeutics (Payers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Digital Therapeutics (Employers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Digital Therapeutics (Employers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Digital Therapeutics (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Digital Therapeutics (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: North America: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: North America: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: United States: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: United States: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Canada: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Canada: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Asia-Pacific: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Asia-Pacific: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: China: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: China: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Japan: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Japan: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: India: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: India: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: South Korea: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: South Korea: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Australia: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Australia: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Indonesia: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Indonesia: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Europe: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Europe: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Germany: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Germany: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: France: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: France: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: United Kingdom: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: United Kingdom: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Italy: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Italy: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Spain: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Spain: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Russia: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Russia: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Latin America: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Latin America: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Brazil: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Brazil: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Mexico: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Mexico: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Middle East and Africa: Digital Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Middle East and Africa: Digital Therapeutics Market: Breakup by Country (in %), 2025
  • Figure 79: Middle East and Africa: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Global: Digital Therapeutics Industry: SWOT Analysis
  • Figure 81: Global: Digital Therapeutics Industry: Value Chain Analysis
  • Figure 82: Global: Digital Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Therapeutics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Digital Therapeutics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 3: Global: Digital Therapeutics Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 4: Global: Digital Therapeutics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Digital Therapeutics Market: Competitive Structure
  • Table 6: Global: Digital Therapeutics Market: Key Players